Physician profile
Jill V Ely
NPI 1528141504
$2,091.40
in general payments reported to CMS, 2019-2025
11 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $366 · 2023: $538 · 2024: $681 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $709.83 | 2023-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $249.42 | 2021-2022 | |
| Insulet Corporation | $235.79 | 2024-2025 | Omnipod |
| Dexcom, INC. | $167.09 | 2023 | Dexcom G7 Gss (161) |
| Mannkind Corporation | $159.39 | 2022-2023 | Afrezza |
| Lilly USA, LLC | $135.51 | 2022-2025 | Jardiance |
| Abbvie INC. | $124.12 | 2022 | |
| Novo Nordisk INC | $120.90 | 2023 | |
| Sequel Med Tech, LLC | $116.67 | 2025 | Twiist |
| Amgen INC. | $55.56 | 2022 | |
| Cequr Corporation | $17.12 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Ely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.